GlassScriptPhysician profile
Ayman Tarabishy
NPI 1568751550
$15,625.06
in general payments reported to CMS, 2019-2025
47 companies · $559 in 2025
The $559 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,264 · 2020: $3,378 · 2021: $3,027 · 2022: $3,691 · 2023: $1,858 · 2024: $1,849 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,265.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,394.10 | 2019-2025 | Proclaim |
| Boston Scientific Corporation | $2,139.50 | 2020-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $1,790.41 | 2019-2024 | Senza |
| Vertos Medical, INC. | $1,437.22 | 2019-2024 | Mild Device Kit |
| Abbvie INC. | $1,226.56 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Nalu Medical, INC. | $429.09 | 2021-2025 | Nalu Neurostimulation System |
| Pfizer INC. | $414.94 | 2019-2025 | |
| Relievant Medsystems, INC. | $361.31 | 2019-2023 | Intracept |
| Biohaven Pharmaceutical Holding Company LTD. | $303.25 | 2022 | |
| Allergan, INC. | $303.13 | 2019-2022 | |
| Medtronic, INC. | $291.22 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Collegium Pharmaceutical, INC. | $285.55 | 2021-2024 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $218.27 | 2021-2025 | Relistor |
| Tersera Therapeutics LLC | $199.98 | 2019-2025 | Prialt |
| Axonics, INC. | $144.92 | 2021-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayman Tarabishy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.